47 research outputs found
Project INTEGRATE: Developing a framework to guide design, implementation and evaluation of people-centred integrated care processes
Background: People-centred integrated care is an acknowledged approach to improve the quality and effectiveness of health systems in delivering care around people’s needs and preferences.
Nevertheless, more guidance on how to effectively design, implement and evaluate the care process of
people-centred integrated care services is needed. Under Project INTEGRATE, a framework was developed
to guide managers in the assessment, transformation and delivery of these health service innovations.
Methods: The framework is a product of the synthesis of operations, service and project management
literature, relevant health care literature, and the analysis of four good practice integrated care case
studies analysed under Project INTEGRATE. A first iteration of the framework was developed and then
applied to one of the integrated care case studies to test its validity and utility.
Results and Discussion: The tool combines a number of important considerations and criteria that have
not been previously included in integrated care assessment frameworks, allowing for a pragmatic and
comprehensive analysis of the care process.
Conclusion: This framework can be used as a stand-alone or combined tool to guide managers to plan and
evaluate the care process design of people-centred integrated care services; future work should apply
this tool to other settings
Artificial pancreas systems for people with type 2 diabetes: Conception and design of the european CLOSE project
In the last 10 years tremendous progress has been made in the development of artificial pancreas (AP) systems for people
with type 1 diabetes (T1D). The pan-European consortium CLOSE (Automated Glucose Control at Home for People with
Chronic Disease) is aiming to develop integrated AP solutions (APplus) tailored to the needs of people with type 2 diabetes
(T2D). APplus comprises a product and service package complementing the AP system by obligatory training as well as home
visits and telemedical consultations on demand. Outcome predictors and performance indicators shall help to identify people
who could benefit most from AP usage and facilitate the measurement of AP impact in diabetes care. In a first step CLOSE
will establish a scalable APplus model case working at the interface between patients, homecare service providers, and payers
in France. CLOSE will then scale up APplus by pursuing geographic distribution, targeting additional audiences, and enhancing
AP functionalities and interconnectedness. By being part of the European Institute of Innovation and Technology (EIT)
Health public-private partnership, CLOSE is committed to the EIT “knowledge triangle” pursuing the integrated advancement
of technology, education, and business creation. Putting stakeholders, education, and impact into the center of APplus
advancement is considered key for achieving wide AP use in T2D care
Measurement of the Ratio of b Quark Production Cross Sections in Antiproton-Proton Collisions at 630 GeV and 1800 GeV
We report a measurement of the ratio of the bottom quark production cross
section in antiproton-proton collisions at 630 GeV to 1800 GeV using bottom
quarks with transverse momenta greater than 10.75 GeV identified through their
semileptonic decays and long lifetimes. The measured ratio
sigma(630)/sigma(1800) = 0.171 +/- .024 +/- .012 is in good agreement with
next-to-leading order (NLO) quantum chromodynamics (QCD)
The global retinoblastoma outcome study : a prospective, cluster-based analysis of 4064 patients from 149 countries
DATA SHARING : The study data will become available online once all analyses are complete.BACKGROUND : Retinoblastoma is the most common intraocular cancer worldwide. There is some evidence to suggest that major differences exist in treatment outcomes for children with retinoblastoma from different regions, but these differences have not been assessed on a global scale. We aimed to report 3-year outcomes for children with retinoblastoma globally and to investigate factors associated with survival. METHODS : We did a prospective cluster-based analysis of treatment-naive patients with retinoblastoma who were diagnosed between Jan 1, 2017, and Dec 31, 2017, then treated and followed up for 3 years. Patients were recruited from 260 specialised treatment centres worldwide. Data were obtained from participating centres on primary and additional treatments, duration of follow-up, metastasis, eye globe salvage, and survival outcome. We analysed time to death and time to enucleation with Cox regression models. FINDINGS : The cohort included 4064 children from 149 countries. The median age at diagnosis was 23·2 months (IQR 11·0–36·5). Extraocular tumour spread (cT4 of the cTNMH classification) at diagnosis was reported in five (0·8%) of 636 children from high-income countries, 55 (5·4%) of 1027 children from upper-middle-income countries, 342 (19·7%) of 1738 children from lower-middle-income countries, and 196 (42·9%) of 457 children from low-income countries. Enucleation surgery was available for all children and intravenous chemotherapy was available for 4014 (98·8%) of 4064 children. The 3-year survival rate was 99·5% (95% CI 98·8–100·0) for children from high-income countries, 91·2% (89·5–93·0) for children from upper-middle-income countries, 80·3% (78·3–82·3) for children from lower-middle-income countries, and 57·3% (52·1-63·0) for children from low-income countries. On analysis, independent factors for worse survival were residence in low-income countries compared to high-income countries (hazard ratio 16·67; 95% CI 4·76–50·00), cT4 advanced tumour compared to cT1 (8·98; 4·44–18·18), and older age at diagnosis in children up to 3 years (1·38 per year; 1·23–1·56). For children aged 3–7 years, the mortality risk decreased slightly (p=0·0104 for the change in slope). INTERPRETATION : This study, estimated to include approximately half of all new retinoblastoma cases worldwide in 2017, shows profound inequity in survival of children depending on the national income level of their country of residence. In high-income countries, death from retinoblastoma is rare, whereas in low-income countries estimated 3-year survival is just over 50%. Although essential treatments are available in nearly all countries, early diagnosis and treatment in low-income countries are key to improving survival outcomes.The Queen Elizabeth Diamond Jubilee Trust and the Wellcome Trust.https://www.thelancet.com/journals/langlo/homeam2023Paediatrics and Child Healt
Nitrogen and phosphorus concentrations in forest streams of the United States
Seventy to eighty percent of the water flowing in rivers in the United States originates as precipitation in forests. This project developed a synoptic picture of the patterns in water chemistry for over 300 streams in small, forested watersheds across the United States. Nitrate (NO3-) concentrations averaged 0.31 mg N/L, with some streams averaging ten times this level. Nitrate concentrations tended to be higher in the northeastern United States in watersheds dominated by hardwood forests (especially hardwoods other than oaks) and in recently harvested watersheds. Concentrations of dissolved organic N (mean 0.32 mg N/L) were similar to those of NO3-, whereas ammonium (NH4+) concentrations were much lower (mean 0.05 mg N/L). Nitrate dominated the N loads of streams draining hardwood forests, whereas dissolved organic N dominated the streams in coniferous forests. Concentrations of inorganic phosphate were typically much lower (mean 12 mg P/L) than dissolved organic phosphate (mean 84 mg P/L). The frequencies of chemical concentrations in streams in small, forested watersheds showed more streams with higher NO3- concentrations than the streams used in national monitoring programs of larger, mostly forested watersheds. At a local scale, no trend in nitrate concentration with stream order or basin size was consistent across studies
Project INTEGRATE: Developing a framework to guide design, implementation and evaluation of people-centred integrated care processes
Background: People-centred integrated care is an acknowledged approach to improve the quality and effectiveness of health systems in delivering care around people’s needs and preferences.
Nevertheless, more guidance on how to effectively design, implement and evaluate the care process of
people-centred integrated care services is needed. Under Project INTEGRATE, a framework was developed
to guide managers in the assessment, transformation and delivery of these health service innovations.
Methods: The framework is a product of the synthesis of operations, service and project management
literature, relevant health care literature, and the analysis of four good practice integrated care case
studies analysed under Project INTEGRATE. A first iteration of the framework was developed and then
applied to one of the integrated care case studies to test its validity and utility.
Results and Discussion: The tool combines a number of important considerations and criteria that have
not been previously included in integrated care assessment frameworks, allowing for a pragmatic and
comprehensive analysis of the care process.
Conclusion: This framework can be used as a stand-alone or combined tool to guide managers to plan and
evaluate the care process design of people-centred integrated care services; future work should apply
this tool to other settings